Dr. Gautam Patel, MD

NPI: 1679764054
Total Payments
$9,977
2024 Payments
$697.57
Companies
35
Transactions
566
Medicare Patients
1,702
Medicare Billing
$225,451

Payment Breakdown by Category

Food & Beverage$9,977 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,977 566 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $1,396 77 $0 (2024)
PFIZER INC. $1,161 81 $0 (2024)
Novartis Pharmaceuticals Corporation $1,067 52 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,000 62 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $958.57 47 $0 (2024)
Electromed, Inc. $932.66 53 $0 (2023)
Merck Sharp & Dohme LLC $557.53 36 $0 (2024)
Otsuka America Pharmaceutical, Inc. $481.72 25 $0 (2019)
ABBVIE INC. $410.06 22 $0 (2024)
Philips Electronics North America Corporation $209.78 11 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $697.57 32 Boehringer Ingelheim Pharmaceuticals, Inc. ($164.70)
2023 $1,112 54 ABBVIE INC. ($184.50)
2022 $1,179 63 Philips Electronics North America Corporation ($209.78)
2021 $1,976 115 Electromed, Inc. ($513.19)
2020 $1,325 79 AstraZeneca Pharmaceuticals LP ($264.62)
2019 $2,100 120 Janssen Pharmaceuticals, Inc ($339.55)
2018 $985.16 66 Novartis Pharmaceuticals Corporation ($136.27)
2017 $601.89 37 Janssen Pharmaceuticals, Inc ($125.92)

All Payment Transactions

566 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
12/05/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $23.42 General
Category: CARDIOVASCULAR
12/04/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.19 General
Category: DIABETES
11/23/2024 ABBVIE INC. DALVANCE (Drug), AVYCAZ, TEFLARO Food and Beverage In-kind items and services $20.22 General
Category: ANTI-INFECTIVE
11/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $20.04 General
Category: DIABETES
11/13/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $16.11 General
Category: Cardiology/Vascular Diseases
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.49 General
Category: Gastroenterology
09/19/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $17.43 General
Category: Cardiology/Vascular Diseases
09/10/2024 ABBVIE INC. DALVANCE (Drug), TEFLARO Food and Beverage In-kind items and services $18.38 General
Category: ANTI-INFECTIVE
09/04/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.72 General
Category: Cardiovascular & Metabolism
08/30/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $17.73 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/15/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $28.37 General
Category: Cardiology/Vascular Diseases
08/07/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.77 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/12/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $16.91 General
Category: Cardiology/Vascular Diseases
06/21/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $13.31 General
Category: ANTIBIOTIC
06/20/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.70 General
Category: Diabetes
06/19/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $18.39 General
Category: Electromedical and Electrotherapeutic Apparatus
06/18/2024 ABBVIE INC. DALVANCE (Drug), TEFLARO Food and Beverage In-kind items and services $18.37 General
Category: ANTI-INFECTIVE
06/07/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $23.45 General
Category: Cardiovascular & Metabolism
06/04/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.53 General
Category: DIABETES
05/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.63 General
Category: DIABETES
05/07/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $25.20 General
Category: INFECTIOUS DISEASE
04/29/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $24.86 General
Category: Cardiovascular
04/24/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $28.99 General
Category: Cardiovascular & Metabolism
04/23/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $34.07 General
Category: DIABETES
03/13/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.83 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 492 892 $246,560 $68,727
2022 7 427 721 $174,143 $53,808
2021 8 455 584 $188,677 $62,325
2020 7 328 405 $117,793 $40,592
Total Patients
1,702
Total Services
2,602
Medicare Billing
$225,451
Procedure Codes
27

All Medicare Procedures & Services

27 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 158 395 $79,000 $23,348 29.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 101 238 $67,354 $21,164 31.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 131 136 $46,920 $11,683 24.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 87 87 $48,894 $11,176 22.9%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 15 36 $4,392 $1,355 30.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 120 269 $65,974 $20,725 31.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 100 223 $37,829 $12,029 31.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 66 66 $30,912 $9,610 31.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 90 92 $24,537 $7,330 29.9%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 18 18 $7,878 $2,129 27.0%
99217 Hospital observation care on day of discharge Facility 2022 20 20 $3,962 $1,038 26.2%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 13 33 $3,051 $945.76 31.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 192 197 $90,423 $30,045 33.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 83 176 $44,592 $14,385 32.3%
99220 Hospital observation care, typically 70 minutes Facility 2021 37 37 $15,614 $5,213 33.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 45 74 $12,210 $4,199 34.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 43 45 $10,980 $3,768 34.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 20 20 $6,220 $2,146 34.5%
99219 Hospital observation care, typically 50 minutes Facility 2021 21 21 $6,468 $1,775 27.4%
99217 Hospital observation care on day of discharge Facility 2021 14 14 $2,170 $795.20 36.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 113 117 $52,606 $18,626 35.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 69 119 $19,493 $6,694 34.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 49 72 $17,434 $5,658 32.5%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 30 30 $9,270 $3,321 35.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 35 35 $8,324 $2,867 34.4%

About Dr. Gautam Patel, MD

Dr. Gautam Patel, MD is a Family Medicine healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679764054.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gautam Patel, MD has received a total of $9,977 in payments from pharmaceutical and medical device companies, with $697.57 received in 2024. These payments were reported across 566 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,977).

As a Medicare-enrolled provider, Patel has provided services to 1,702 Medicare beneficiaries, totaling 2,602 services with total Medicare billing of $225,451. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Hospitalist, Family Medicine
  • Location Matthews, NC
  • Active Since 08/09/2007
  • Last Updated 06/14/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1679764054

Products in Payments

  • XARELTO (Drug) $1,396
  • ENTRESTO (Drug) $976.10
  • SMARTVEST (Device) $932.66
  • ELIQUIS (Drug) $930.38
  • BRILINTA (Drug) $554.45
  • JARDIANCE (Drug) $431.85
  • SAMSCA (Drug) $384.34
  • TEFLARO (Drug) $324.59
  • ZERBAXA (Drug) $313.57
  • SPIRIVA RESPIMAT (Drug) $262.90
  • DALVANCE (Drug) $256.51
  • LOKELMA (Drug) $237.23
  • (8874) inCourage (Device) $209.78
  • DIFICID (Drug) $200.50
  • NUZYRA (Drug) $194.92
  • CHANTIX (Drug) $166.14
  • LifeVest (Device) $133.59
  • VYNDAQEL (Drug) $104.40
  • JYNARQUE (Drug) $97.38
  • Orbactiv (Drug) $94.06

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Matthews